<td></td>

Agent XV-112

An artificial cross between Anthrax and the Ebola virus, has created this deadly biological agent. Agent XV-112 is highly contagous, and kills the carrier within 72 hours of first contact. Computer predictions have shown that after first release in a large nation (over 1,000,000,000 people), over 75% of the population are killed within 7 months. Symptoms include blisters, sever respitory distress, and cardiac arrest.

Ultra High Radiation Warhead (UHR)

This is a warhead, that is loaded into TCN specification ICBM's, and can be dropped by bombers. Upon detonation very little physical damage is caused, but massive amounts of radiation is released. Tests have shown that over 20 miles from the point of impact, 50–80 Sv (5,000–8,000 REM) is dectected. This much radiation causes immediate disorientation and coma in seconds or minutes. Death occurs after a few hours by total collapse of nervous system, and causes death in 100% of cases. It is predicted that there is 100 times this at the point of impact. 30 miles from the point of impact, tests have shown that 10–50 Sv (1,000–5,000 REM) is detected. This causes acute radiation poisoning, 100% fatality after 7 days (LD 100/7). A dose this high leads to spontaneous symptoms after 5 to 30 minutes. After powerful fatigue and immediate nausea caused by direct activation of chemical receptors in the brain by the irradiation, there is a period of several days of comparable well-being, called the latent (or "walking ghost") phase. After that, cell death in the gastric and intestinal tissue, causing massive diarrhea, intestinal bleeding and loss of water, leads to water-electrolyte imbalance. Death sets in with delirium and coma due to breakdown of circulation. Death is inevitable; the only treatment that can be offered is pain therapy. 60 miles away from the point of impact, tests have show that 4–6 Sv (400–600 REM) is dectected. This causes acute radiation poisoning, 60% fatality after 30 days (LD 60/30). Fatality increases from 60% at 4.5 Sv to 90% at 6 Sv (unless there is intense medical care). Symptoms start half an hour to two hours after irradiation and last for up to 2 days. After that, there is a 7 to 14 day latent phase (or anastasis), after which generally the same symptoms appear as with 3-4 Sv irradiation, with increased intensity. Female sterility is common at this point. Convalescence takes several months to a year. The primary causes of death (in general 2 to 12 weeks after irradiation) are infections and internal bleeding. 100 miles away from the point of impact 0.2–0.5 Sv (20–50 REM) has been detected. There are no noticeable symptoms. Red blood cell count decreases temporarily. All above data was collected on the only test of the UHR warhead, conducted on an offshore island, about 90 miles from TCN's northers coast. It is predicted that this test caused the death of about 300 TCN citizens. This is one of TCN's most devistation weapons. Currently there are 3 Mark-1 Warheads. Mark-2 Warheads are currently in development, and 25 are to be commissioned for TCAF. Mark-2's are expected to reach service in 2006, with 1 being produced every 6 months after this, at a cost of T1,000,000,000 each unit.

Projects Currently in Development

The Advanced Devivery Missile System (ADMS)

This was a missile based on the Multiple Independently Targetable Reentry Vehicle design. This means that they can strike a number of targets with a single missile. The ADMS missile has measures designed to counter anti-ballistic missiles, and aircraft. The ADMS missles are designed to carry warheads only of AdCap Program design, making sure that only TCN could use them.

Orbital Weaponary

Currently still in planning phase it is believed that the first prototype is expected in 2012.

The Future Force Warrior

With the development of a bionic uniform for its soldiers, TCAF is planning for a change in the logistics of war. Integrated physiological monitoring, enhanced communication and augmented physical strength will give the soldiers of the future the tools they need to overwhelm their opponents simply by donning a hi-tech suit. There are two phases to the Future Force Warrior program. The first phase involves the deployment of a uniform in 2010 that will meet the Army's short-term needs, although pieces of the uniform may be deployed earlier. According to Future Force Warrior Equipment Specialist Jean-Louis "Dutch" DeGay, "The Department of the Army has built what's called design spirals, so roughly every two years, if a piece of technology has matured, we try to get it in the field, rather than waiting until 2010 to field the entire system." In 2020, the U.S. Army will roll out a suit that integrates nanotechnology, exoskeletons and liquid body armor, all of which exist only in concept now.

Here are the basic components of the final version of the suit:

Helmet - The helmet houses a GPS receiver, radio and the wide- and local-area network connections.

Warrior Physiological Status Monitoring System - This layer of the suit is the closest to the body and contains sensors that monitor physiological indicators, such as heart rate, blood pressure and hydration. The suit relays the information to medics and field commanders.

Liquid Body Armor - This liquid body armor is made from magnetorheological fluid, a fluid that remains in a liquid state until the application of a magnetic field. When an electrical pulse is applied, the armor transitions from a soft state to a rigid state in thousandths of a second.

Exoskeleton - The exoskeleton is made of lightweight, composite devices that attach to the legs and augment the soldier's strength.